We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
EMA要求对Vocabria（卡博特韦+利匹韦林）进行长期监测，原因是存在肝毒性、妊娠结局和耐药性风险。了解研究结果和影响。
